Latest From Unilever PLC
Tucker Ellis attorney Ronie Schmelz discusses uncertainties companies face in marketing CBD-containing cosmetics and measures they can take to mitigate risks ahead of expected regulatory guidance.
The turnaround-minded direct seller confirmed in late March that it was in discussions with Natura about a potential transaction. Natura prides itself on its cruelty-free status, and Avon increasingly seems like it could be a good fit in that regard.
Nakissa Sadrieh, director of cosmetics at FDA and the agency’s CIR liaison, floated the three potential review priorities at the CIR Expert Panel’s April 8-9 meeting in Washington. It’s the most for-cause targets proposed by the agency in recent memory, and CIR leadership noted that they pose considerable challenges.
Fluocaril and Parogencyl are “well-known” toothpastes that have garnered “strong endorsement from health professionals,” Unilever says. The brands, identified by analysts as potential candidates for sale, are latest in P&G’s ongoing trimming of lower-selling lines.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Unilever PLC
- Senior Management
- Paul Polman, CEO
- Contact Info
Phone: (44) 20 7 822 5252
Unilever House, Blackfriars
P.O. Box 68
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.